Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • ZIOPHARM ONCOLOGY INC Financial Overview

  • Income Statement: ZIOP

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 0.00 0.00 0.00 N/A%
    Gross Profit -388,000.00 -433,353.00 45,353.00 -11.69%
    Net Income Before Extra Items/Preferred Div -25.23 M -26.61 M 1.38 M -5.46%
    Operating Income -25.62 M -28.57 M 2.95 M -11.52%
  • Cash Flow: ZIOP

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 0.00 29.01 M -29.01 M -∞ T%
    Net Cash Flow - Investing 131,000.00 -817,049.00 948,049.00 723.70%
    Net Cash Flow/Operating Activities -23.52 M -21.65 M -1.87 M 7.95%
  • Balance Sheet: ZIOP

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 12.57 M 36.73 M -24.15 M -192.11%
    Total Liabilities 5.83 M 6.36 M -522,638.00 -8.96%
    Shareholders Equity 6.74 M 30.37 M -23.63 M -350.66%
  • Key Ratios / Statistics: ZIOP

    • Valuation

      Price/Earnings (TTM) -0.49
      Price/Sales (TTM)
      Price/Book (MRQ) 21.17
      Price/Cash Flow (TTM) -5.27
    • Profitability

      Gross Margin
      Operating Margin
      Profit Margin
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 1.97
      Current Ratio (MRQ) 1.39
      Long Term Debt-to-Equity (MRQ) 0.00
    • Management Effectiveness

      Return on Equity (TTM) -137.24
      Return on Assets (TTM) -113.63
      Return on Investments (TTM) -135.98